Plant ID: NPO26868
Plant Latin Name: Diphylleia sinensis
Taxonomy Genus: Diphylleia
Taxonomy Family: Berberidaceae
NCBI TaxonomyDB:
382113
Plant-of-the-World-Online:
n.a.
Antiseptic; Cancer
China
NPSR1; | |
CTDSP1; TDP1; HSD17B1; AKR1B1; HSD17B2; ALOX15; NOX4; | |
DAPK1; FLT3; | |
CA2; CA12; CA7; | |
AR; | |
ESRRA; | |
ALOX5; TYR; XDH; | |
AHR; HIF1A; TP53; | |
ABCG2; ABCC1; | |
HTT; LMNA; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
ATP-binding cassette | ABCG2 | ATP-binding cassette sub-family G member 2 | Q9UNQ0 | CHEMBL5393 |
ATP-binding cassette | ABCC1 | Multidrug resistance-associated protein 1 | P33527 | CHEMBL3004 |
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 family 1 | CYP1B1 | Cytochrome P450 1B1 | Q16678 | CHEMBL4878 |
Cytochrome P450 family 1 | CYP1A1 | Cytochrome P450 1A1 | P04798 | CHEMBL2231 |
Cytochrome P450 family 2 | CYP2C19 | Cytochrome P450 2C19 | P33261 | CHEMBL3622 |
Cytochrome P450 family 2 | CYP2C9 | Cytochrome P450 2C9 | P11712 | CHEMBL3397 |
Enzyme_unclassified | CTDSP1 | Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 | Q9GZU7 | CHEMBL1795098 |
Enzyme_unclassified | TDP1 | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | CHEMBL1075138 |
Enzyme_unclassified | HSD17B1 | Estradiol 17-beta-dehydrogenase 1 | P14061 | CHEMBL3181 |
Enzyme_unclassified | AKR1B1 | Aldose reductase | P15121 | CHEMBL1900 |
Enzyme_unclassified | HSD17B2 | Estradiol 17-beta-dehydrogenase 2 | P37059 | CHEMBL2789 |
Enzyme_unclassified | ALOX15 | Arachidonate 15-lipoxygenase | P16050 | CHEMBL2903 |
Enzyme_unclassified | NOX4 | NADPH oxidase 4 | Q9NPH5 | CHEMBL1250375 |
Lyase | CA2 | Carbonic anhydrase II | P00918 | CHEMBL205 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Nuclear hormone receptor subfamily 3 group B | ESRRA | Estrogen-related receptor alpha | P11474 | CHEMBL3429 |
Nuclear hormone receptor subfamily 3 group C | AR | Androgen Receptor | P10275 | CHEMBL1871 |
Oxidoreductase | ALOX5 | Arachidonate 5-lipoxygenase | P09917 | CHEMBL215 |
Oxidoreductase | TYR | Tyrosinase | P14679 | CHEMBL1973 |
Oxidoreductase | XDH | Xanthine dehydrogenase | P47989 | CHEMBL1929 |
Peptide receptor (family A GPCR) | NPSR1 | Neuropeptide S receptor | Q6W5P4 | CHEMBL5162 |
Protein Kinase | DAPK1 | Death-associated protein kinase 1 | P53355 | CHEMBL2558 |
Protein Kinase | FLT3 | Tyrosine-protein kinase receptor FLT3 | P36888 | CHEMBL1974 |
Transcription Factor | AHR | Aryl hydrocarbon receptor | P35869 | CHEMBL3201 |
Transcription Factor | HIF1A | Hypoxia-inducible factor 1 alpha | Q16665 | CHEMBL4261 |
Transcription Factor | TP53 | Cellular tumor antigen p53 | P04637 | CHEMBL4096 |
Unclassified | HTT | Huntingtin | P42858 | CHEMBL5514 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 1.595E-12 | 3.102E-08 | CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2C9 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 6.436E-11 | 2.247E-07 | CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2C9, NOX4 |
MF | GO:0005488; binding | GO:0005506; iron ion binding | 9.318E-11 | 2.536E-07 | ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2C9, XDH |
BP | GO:0008152; metabolic process | GO:0019373; epoxygenase P450 pathway | 1.273E-10 | 2.771E-07 | CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2C9 |
MF | GO:0005488; binding | GO:0020037; heme binding | 3.922E-08 | 3.882E-05 | CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2C9, NOX4 |
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 6.740E-08 | 5.870E-05 | CYP1A2, CYP2C19, CYP2C9 |
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 7.367E-07 | 4.456E-04 | CYP1A2, CYP2C19, CYP2C9 |
BP | GO:0050896; response to stimulus | GO:0033993; response to lipid | 9.570E-07 | 5.343E-04 | AR, CA2, CYP1A1, CYP1A2, ESRRA, FLT3, HSD17B2, TP53, TYR |
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 1.519E-06 | 7.875E-04 | CA12, CA2, CA7 |
BP | GO:0008152; metabolic process | GO:2000377; regulation of reactive oxygen species metabolic process | 5.768E-06 | 2.364E-03 | CYP1B1, HIF1A, NOX4, TP53, XDH |
BP | GO:0008152; metabolic process | GO:0009404; toxin metabolic process | 5.863E-06 | 2.364E-03 | CYP1A1, CYP1A2, CYP1B1 |
MF | GO:0003824; catalytic activity | GO:0070330; aromatase activity | 5.863E-06 | 2.364E-03 | CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0009987; cellular process | GO:0032849; positive regulation of cellular pH reduction | 6.989E-06 | 2.624E-03 | CA2, CA7 |
BP | GO:0032502; developmental process | GO:0048513; animal organ development | 7.317E-06 | 2.700E-03 | AR, CA2, CYP1A1, CYP1A2, ESRRA, FLT3, HIF1A, HSD17B2, HTT, TYR |
BP | GO:0050896; response to stimulus | GO:0010038; response to metal ion | 8.227E-06 | 2.958E-03 | ALOX15, CA2, CYP1A1, CYP1A2, HIF1A, TP53 |
BP | GO:0009987; cellular process | GO:0034599; cellular response to oxidative stress | 1.128E-05 | 3.559E-03 | AKR1B1, CYP1B1, DAPK1, NOX4, TP53 |
BP | GO:0008152; metabolic process | GO:0017144; drug metabolic process | 1.292E-05 | 3.906E-03 | ABCC1, AKR1B1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2C9 |
BP | GO:0008152; metabolic process | GO:0018894; dibenzo-p-dioxin metabolic process | 1.396E-05 | 4.001E-03 | CYP1A1, CYP1A2 |
MF | GO:0003824; catalytic activity | GO:0034875; caffeine oxidase activity | 1.396E-05 | 4.001E-03 | CYP1A2, CYP2C9 |
BP | GO:0008152; metabolic process | GO:0006691; leukotriene metabolic process | 1.476E-05 | 4.173E-03 | ABCC1, ALOX15, ALOX5 |
BP | GO:0009987; cellular process | GO:2001237; negative regulation of extrinsic apoptotic signaling pathway | 1.878E-05 | 5.076E-03 | AR, DAPK1, HTT, LMNA |
BP | GO:0008283; cell proliferation | GO:0042127; regulation of cell proliferation | 1.890E-05 | 5.076E-03 | AHR, AKR1B1, AR, CYP1B1, ESRRA, FLT3, HIF1A, LMNA, NOX4, TP53, XDH |
MF | GO:0003824; catalytic activity | GO:0008395; steroid hydroxylase activity | 1.958E-05 | 5.076E-03 | CYP1A1, CYP2C19, CYP2C9 |
BP | GO:0065007; biological regulation | GO:0030003; cellular cation homeostasis | 2.047E-05 | 5.243E-03 | ABCG2, CA2, CA7, HIF1A, HTT, NPSR1, TP53 |
MF | GO:0003824; catalytic activity | GO:0009055; electron transfer activity | 2.264E-05 | 5.667E-03 | AKR1B1, CYP1A2, NOX4, XDH |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 2.332E-05 | 5.761E-03 | CA12, CA2, CA7 |
BP | GO:0008152; metabolic process | GO:2001300; lipoxin metabolic process | 3.484E-05 | 8.247E-03 | ALOX15, ALOX5 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 4.289E-05 | 9.831E-03 | CA12, CA2, CA7 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09150 Organismal Systems | 09152 Endocrine system | hsa04913 | Ovarian steroidogenesis | 1.081E-08 | 8.323E-07 | HSD17B1, ALOX5, HSD17B2, CYP1A1, CYP1B1 |
09100 Metabolism | 09103 Lipid metabolism | hsa00140 | Steroid hormone biosynthesis | 2.318E-08 | 8.925E-07 | HSD17B1, CYP1A2, HSD17B2, CYP1A1, CYP1B1 |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 9.019E-07 | 1.389E-05 | CYP2C9, HSD17B1, ALOX5, HSD17B2, CYP1A2, ALOX15, CYP1A1, AKR1B1, CYP2C19, TYR, XDH |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 9.516E-08 | 2.442E-06 | CYP2C9, CYP1A2, ALOX15, CYP2C19 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 1.346E-07 | 2.592E-06 | CYP2C9, CYP1A2, CYP1A1, CYP1B1, CYP2C19 |
09100 Metabolism | 09103 Lipid metabolism | hsa00590 | Arachidonic acid metabolism | 2.159E-06 | 2.375E-05 | CYP2C9, ALOX5, ALOX15, CYP2C19 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 4.165E-06 | 4.009E-05 | CYP2C9, CYP1A2, CYP1A1, CYP1B1 |
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 2.282E-05 | 1.757E-04 | CYP2C9, ALOX5, ALOX15, CYP2C19 |
09100 Metabolism | 09105 Amino acid metabolism | hsa00380 | Tryptophan metabolism | 2.898E-05 | 2.029E-04 | CYP1A2, CYP1A1, CYP1B1 |
09160 Human Diseases | 09161 Cancers | hsa05200 | Pathways in cancer | 2.844E-04 | 1.460E-03 | AR, FLT3, DAPK1, HIF1A, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05230 | Central carbon metabolism in cancer | 1.367E-04 | 8.099E-04 | FLT3, TP53, HIF1A |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 1.249E-04 | 8.017E-04 | CYP2C9, CYP1A2, CYP1A1 |
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 2.042E-06 | 2.375E-05 | CA12, CA2, CA7 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 1.493E-04 | 8.209E-04 | CYP2C9, CYP1A2, CYP2C19 |
09160 Human Diseases | 09161 Cancers | hsa05219 | Bladder cancer | 1.720E-03 | 8.277E-03 | DAPK1, TP53 |
09130 Environmental Information Processing | 09131 Membrane transport | hsa02010 | ABC transporters | 1.979E-03 | 8.962E-03 | ABCC1, ABCG2 |
09100 Metabolism | 09110 Biosynthesis of other secondary metabolites | hsa00232 | Caffeine metabolism | 2.169E-05 | 1.757E-04 | CYP1A2, XDH |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
C00-D49: Neoplasms | Melanoma | C43 | TYR; |
L00-L99: Diseases of the skin and subcutaneous tissue | Melasma | L81.1 | TYR; |
NA: NA | HIV infections | NA | AHR; |
C00-D49: Neoplasms | Multiple myeloma | C90 | AHR; |
L00-L99: Diseases of the skin and subcutaneous tissue | Vitiligo | L80 | TYR; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Rheumatoid arthritis | M05-M06 | TYR; |